Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-25 18:39 |
6-K
|
English | 308.9 KB | ||
| 2024-10-25 07:30 |
Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipate…
|
English | 359.8 KB | ||
| 2024-10-25 07:30 |
Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par un…
|
French | 381.9 KB | ||
| 2024-10-24 14:00 |
Communiqué de presse : Dupixent : Présentation de nouvelles données positives d…
|
French | 263.6 KB | ||
| 2024-10-24 14:00 |
Press Release: Dupixent late-breaking positive phase 3 data in chronic spontane…
|
English | 255.4 KB | ||
| 2024-10-21 17:47 |
6-K
|
English | 82.3 KB | ||
| 2024-10-21 07:30 |
Communiqué de presse : Sanofi et CD&R s’allient pour soutenir les ambitions d’O…
|
French | 224.8 KB | ||
| 2024-10-21 07:30 |
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer h…
|
English | 213.6 KB | ||
| 2024-10-17 07:30 |
Communiqué de presse : Sanofi et Orano Med unissent leurs forces pour développe…
|
French | 288.8 KB | ||
| 2024-10-17 07:30 |
Press Release: Sanofi and Orano join forces to develop next-generation radiolig…
|
English | 283.4 KB | ||
| 2024-10-15 22:05 |
Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTE…
|
French | 121.4 KB | ||
| 2024-10-15 22:05 |
Sanofi: Information concerning the total number of voting rights and shares - S…
|
English | 145.3 KB | ||
| 2024-10-11 21:35 |
6-K
|
English | 37.5 KB | ||
| 2024-10-11 08:30 |
Communiqué de presse : Sanofi en discussions pour céder une participation major…
|
French | 133.2 KB | ||
| 2024-10-11 08:30 |
Press Release: Sanofi in discussions to sell a controlling stake in Opella
|
English | 127.2 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
